Celldex

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Celldex and other ETFs, options, and stocks.

About CLDX

Celldex Therapeutics, Inc. engages in the business of development, manufacturing and commercialization of novel therapeutics for human health care. Its drug candidates have the ability to engage the human immune system and directly inhibit tumors to treat specific types of cancer and other diseases. 

CEO
Anthony S. Marucci
CEOAnthony S. Marucci
Employees
198
Employees198
Headquarters
Hampton, New Jersey
HeadquartersHampton, New Jersey
Founded
1983
Founded1983
Employees
198
Employees198

CLDX Key Statistics

Market cap
2.79B
Market cap2.79B
Price-Earnings ratio
-8.28
Price-Earnings ratio-8.28
Dividend yield
Dividend yield
Average volume
909.68K
Average volume909.68K
High today
$36.57
High today$36.57
Low today
$35.39
Low today$35.39
Open price
$36.05
Open price$36.05
Volume
49.85K
Volume49.85K
52 Week high
$40.30
52 Week high$40.30
52 Week low
$19.72
52 Week low$19.72

Stock Snapshot

The current Celldex(CLDX) stock price is $35.57, with a market capitalization of 2.79B. The stock trades at a price-to-earnings (P/E) ratio of -8.28.

On 2026-07-20, Celldex(CLDX) stock traded between a low of $35.39 and a high of $36.57. Shares are currently priced at $35.57, which is +0.5% above the low and -2.7% below the high.

Celldex(CLDX) shares are trading with a volume of 49.85K, against a daily average of 909.68K.

During the past year, Celldex(CLDX) stock moved between $19.72 at its lowest and $40.30 at its peak.

During the past year, Celldex(CLDX) stock moved between $19.72 at its lowest and $40.30 at its peak.

CLDX News

Nasdaq 3h
Eton Pharmaceuticals Moves 13.8% Higher: Will This Strength Last?

Eton Pharmaceuticals, Inc. (ETON) shares soared 13.8% in the last trading session to close at $42.32. The move was backed by solid volume with far more shares c...

Eton Pharmaceuticals Moves 13.8% Higher: Will This Strength Last?
Investing.com 5d
Celldex CFO Sam Martin to retire in March 2027 - Investing.com

...

Celldex CFO Sam Martin to retire in March 2027 - Investing.com
TipRanks 5d
Celldex CFO Sam Martin to retire in 2027

Celldex (CLDX) announced that Sam Martin, senior VP and CFO, has informed the company of his plans to retire in 2027. Martin has served as the company’s CFO sin...

Analyst ratings

94%

of 16 ratings
Buy
93.8%
Hold
6.3%
Sell
0%

People also own

Based on the portfolios of people who own CLDX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.